Brief: Initiator Pharma Receives Intention To Grant Notice For Patent Application
Jan 30 (Reuters) - INITIATOR PHARMA A/S INIT.TE :
* INITIATOR PHARMA RECEIVES AN INTENTION TO GRANT NOTICE IN
EUROPE
FOR ITS PIPELINE PRODUCT CANDIDATE IPDP2015 FOR TREATMENT OF
DEPRESSION
* SAYS PATENT, WHEN GRANTED, PROVIDES PROTECTION OF
IPDP2015 IN
EUROPE UNTIL 2029
Source text for Eikon: ID:nWkr8Mz9Cs
Further company coverage: INIT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD